PL3498262T3 - Kwas hialuronowy - żel do wstrzykiwania - Google Patents

Kwas hialuronowy - żel do wstrzykiwania

Info

Publication number
PL3498262T3
PL3498262T3 PL19156054T PL19156054T PL3498262T3 PL 3498262 T3 PL3498262 T3 PL 3498262T3 PL 19156054 T PL19156054 T PL 19156054T PL 19156054 T PL19156054 T PL 19156054T PL 3498262 T3 PL3498262 T3 PL 3498262T3
Authority
PL
Poland
Prior art keywords
hyaluronic acid
injectable gel
acid injectable
gel
hyaluronic
Prior art date
Application number
PL19156054T
Other languages
English (en)
Inventor
Samuel Gavard Molliard
Olivier Benoit
Original Assignee
Aptissen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3498262(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aptissen Sa filed Critical Aptissen Sa
Publication of PL3498262T3 publication Critical patent/PL3498262T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
PL19156054T 2007-07-02 2008-07-02 Kwas hialuronowy - żel do wstrzykiwania PL3498262T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0704772A FR2918276B1 (fr) 2007-07-02 2007-07-02 "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
PCT/FR2008/000948 WO2009024670A2 (fr) 2007-07-02 2008-07-02 Gel injectable d ' acide hyaluronique pour le traitement des degenerescences articulaires
EP19156054.9A EP3498262B1 (fr) 2007-07-02 2008-07-02 Gel injectable d'acide hyaluronique
EP08827889.0A EP2173324B1 (fr) 2007-07-02 2008-07-02 Gel injectable d'acide hyaluronique pour le traitement des degenerescences articulaires

Publications (1)

Publication Number Publication Date
PL3498262T3 true PL3498262T3 (pl) 2022-02-07

Family

ID=39167393

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19156054T PL3498262T3 (pl) 2007-07-02 2008-07-02 Kwas hialuronowy - żel do wstrzykiwania
PL08827889T PL2173324T3 (pl) 2007-07-02 2008-07-02 Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL08827889T PL2173324T3 (pl) 2007-07-02 2008-07-02 Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów

Country Status (14)

Country Link
US (1) US9138405B2 (pl)
EP (2) EP3498262B1 (pl)
JP (1) JP5517133B2 (pl)
KR (1) KR20100028582A (pl)
CN (2) CN101686936A (pl)
BR (1) BRPI0813011B8 (pl)
CA (1) CA2691600C (pl)
ES (2) ES2735376T3 (pl)
FR (1) FR2918276B1 (pl)
HU (1) HUE056793T2 (pl)
PL (2) PL3498262T3 (pl)
PT (2) PT3498262T (pl)
TR (1) TR201909779T4 (pl)
WO (1) WO2009024670A2 (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945949B1 (fr) * 2009-05-26 2011-05-13 Anteis Sa Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
US8273725B2 (en) 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
FR2954165B1 (fr) * 2009-12-18 2012-01-13 Jean-Noel Thorel Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes
JP5457238B2 (ja) * 2010-03-17 2014-04-02 電気化学工業株式会社 ヒアルロン酸及び／又はその塩の含有液の加熱滅菌方法
IT1402382B1 (it) * 2010-09-09 2013-09-04 Ibsa Inst Biochimique Sa Complessi cooperativi ibridi di acido ialuronico
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
WO2012143876A1 (en) * 2011-04-19 2012-10-26 Anteis S.A. A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
US8623839B2 (en) * 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
GB201118586D0 (en) * 2011-10-27 2011-12-07 Turzi Antoine New A-PRP medical device, manufacturing machine and process
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases
WO2013076162A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Formulations useful in the treatment of osteoarticular diseases
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
HK1214618A1 (zh) * 2013-01-11 2016-07-29 Carbylan Therapeutics, Inc. 含有透明質酸的穩定化組合物
PT3613423T (pt) * 2013-07-10 2022-12-07 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
KR101582380B1 (ko) * 2013-09-11 2016-01-05 주식회사 제네웰 손상 조직에 대한 세포 전달 및 조직 재생용 생체재료와 제조방법
WO2015077736A1 (en) 2013-11-25 2015-05-28 Deuteria Biomaterials, Llc Deuterium-enriched hyaluronan
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
FR3032617B1 (fr) * 2015-02-16 2018-03-16 Kylane Laboratoires Sa Procede de preparation d un hydrogel injectable; hydrogel obtenu; utilisation de l hydrogel obtenu
PT3352766T (pt) 2015-09-24 2022-03-22 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e processos para o seu uso
CN105879124B (zh) * 2016-04-26 2019-03-19 华熙福瑞达生物医药有限公司 一种注射用左旋聚乳酸填充剂及其制备方法
KR101916193B1 (ko) 2016-08-25 2018-11-07 주식회사 파마리서치프로덕트 핵산 및 키토산을 포함하는 관절강 주사용 조성물
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
FR3063649B1 (fr) * 2017-03-07 2021-05-21 Laboratoire De Rhumatologie Appliquee Nouvelle solution visco-elastique et son utilisation en rhumatologie
BR112020003767B1 (pt) 2017-08-22 2023-10-10 Moebius Medical Ltd Composição farmacêutica que compreende lipossomas e uso da dita composição para tratar dor ou irritação em uma articulação
IT201800007683A1 (it) 2018-07-31 2020-01-31 Altergon Sa Composizioni cooperative sinergiche utili per aumento del tessuto molle, rilascio di farmaco e campi correlati
KR102566287B1 (ko) * 2018-11-30 2023-08-11 주식회사 엘지화학 히알루론산을 포함하는 활액보충재용 조성물
WO2020154305A1 (en) 2019-01-21 2020-07-30 Eclipse Medcorp, Llc Methods, systems and apparatus for separating components of a biological sample
US12007382B2 (en) 2019-10-31 2024-06-11 Crown Laboratories, Inc. Systems, methods and apparatus for separating components of a sample
CN114667103A (zh) 2019-11-04 2022-06-24 柯惠有限合伙公司 用于治疗颅内动脉瘤的装置、系统和方法
EP3854377A1 (fr) * 2020-01-22 2021-07-28 Laboratoires Genevrier Sas Composition comprenant de l'acide hyaluronique et un polyol ou de carboxyméthylcellulose
WO2022198208A1 (en) 2021-03-16 2022-09-22 Covidien Lp Injectable biopolymer compositions and associated systems and methods
CA3266614A1 (en) 2023-01-19 2024-07-25 Moebius Medical Ltd. LONG-ACTING LIPOSOMAL COMPOSITION FOR THE TREATMENT OF PAIN IN JOINT DISORDERS
WO2025133721A1 (en) * 2023-12-19 2025-06-26 Universidade Nova De Lisboa Injectable composition of nonsteroidal anti-inflammatory drugs, methods and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US5079236A (en) 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
JP2756131B2 (ja) * 1987-07-01 1998-05-25 ジェネンテク，インコーポレイテッド フィブリンの沈着または癒着の予防のための方法および治療学的組成物
JP2788340B2 (ja) * 1989-12-21 1998-08-20 株式会社ニッショー 炎症治療剤
US5095037B1 (en) * 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US7968110B2 (en) * 1992-02-11 2011-06-28 Merz Aesthetics, Inc. Tissue augmentation material and method
IT1291291B1 (it) * 1997-04-30 1999-01-07 Chemedica Sa Uso di acido ialuronico e relativi sali per la preparazione di una soluzione acquosa utile come liquido di lavaggio intra-articolare
WO2003061626A1 (en) * 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
WO2004073759A1 (en) 2003-02-19 2004-09-02 Aventis Pharmaceuticals Holdings Inc. Composition and method for intradermal soft tissue augmentation
US20050208095A1 (en) * 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
US20050215516A1 (en) 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
AU2005272578A1 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors
WO2006067608A1 (en) * 2004-12-22 2006-06-29 Laboratoire Medidom S.A. Aqueous formulations based on sodium hyaluronate for parenteral use
FR2895907B1 (fr) * 2006-01-06 2012-06-01 Anteis Sa Gel viscoelastique a usage dermatologique
FR2909560B1 (fr) 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique

Also Published As

Publication number Publication date
FR2918276A1 (fr) 2009-01-09
CN104825482A (zh) 2015-08-12
HUE056793T2 (hu) 2022-03-28
PL2173324T3 (pl) 2019-09-30
EP2173324B1 (fr) 2019-04-10
JP2010531863A (ja) 2010-09-30
BRPI0813011B8 (pt) 2021-05-25
ES2898939T3 (es) 2022-03-09
CA2691600C (fr) 2017-01-10
US9138405B2 (en) 2015-09-22
BRPI0813011A2 (pt) 2014-12-23
PT2173324T (pt) 2019-07-09
US20100184720A1 (en) 2010-07-22
WO2009024670A2 (fr) 2009-02-26
TR201909779T4 (tr) 2019-07-22
CN101686936A (zh) 2010-03-31
PT3498262T (pt) 2021-11-11
CA2691600A1 (fr) 2009-02-26
WO2009024670A3 (fr) 2009-04-23
EP2173324A2 (fr) 2010-04-14
ES2735376T3 (es) 2019-12-18
KR20100028582A (ko) 2010-03-12
EP3498262B1 (fr) 2021-09-01
FR2918276B1 (fr) 2010-01-22
JP5517133B2 (ja) 2014-06-11
BRPI0813011B1 (pt) 2019-10-08
EP3498262A1 (fr) 2019-06-19

Similar Documents

Publication Publication Date Title
PT3498262T (pt) Gel injetável de ácido hialurónico
ZA200903919B (en) Hyaluronic acid gel for intradermal injection
GB0816496D0 (en) Hyaluronic acid cryogel
SG10202104803SA (en) Hyaluronic Acid-Based Gels Including Anesthetic Agents
ZA201007022B (en) Carbohydrate gel
IL237392A0 (en) Pharmaceutical combination
PL2918172T3 (pl) Połączenia środków kontroli biologicznej i fungicydów
GB2481542B (en) Lighting unit
IL207798A0 (en) Furlable shape-memory relector
HUE047235T2 (hu) Befecskendezhetõ biológiai anyagok
PT2011816T (pt) Gel de polissacáridos co-reticulado
GB0810615D0 (en) Novel pharmaceutical
IL208953A0 (en) Pharmaceutical combination
GB0917736D0 (en) Gel composition
GB0810617D0 (en) Novel pharmaceutical
GB0818926D0 (en) Sealant
GB0801321D0 (en) Gel composition
HU0800414D0 (en) Pharmaceutical combination
GB0811637D0 (en) Hyaluronic acid crtogel
GB0813299D0 (en) Injectable medications
AU2009901028A0 (en) Injectable biomaterials
GB0820320D0 (en) Biomaterials
GB0807271D0 (en) Syringes
GB0804486D0 (en) Novel pharmaceutical composituons
GB0719869D0 (en) Biomaterials